Cancer is a frightening diagnosis for patients. Invaded by disease and poisoned by medications, they may allow their life to be defined by prognosis, dosage and illness. They put that life into the hands of healthcare professionals who will try to save the life and the quality of it. An issue that needs to be addressed in the quality of life of cancer is a patient’s sexual health. How will their treatment affect their sexuality and sexual function? In particular, survivors of prostate and breast cancer need directed focus on their sexual health. Will prostate cancer inhibit a patient’s ability to have an erection? Will a survivor of breast cancer feel sexually attractive after her mastectomy? These, and many more questions, will be addressed in a talk by Drs. Michael Herman and Shari Goldfarb.
Dr. Michael Herman completed his BA at Harvard, his MD at the University of Texas Southwestern Medical Center, and his residency at Weill Cornell Medical College, where he went on to become an Instructor in the Department of Urology. During his residency, Dr. Herman won Physician of the Year, New York-Presbyterian Hospital (2008), First place for AUA/Gyrus Prize Essay Contest (2009), and the Distinguished Housestaff Award, New York-Presbyterian Hospital (2010). He is part of the Center for Prostate Cancer at Weill Cornell Medical College, where they focus on treating all aspects of prostate cancer, including diagnosis, active surveillance, surgery, and post-op recovery, including sexual rehabilitation. Dr. Herman continues to publish research and at this time has co-authored 16 peer-reviewed journal articles, three book chapters, and multiple abstracts. His current research interests include comparative effectiveness research within prostate cancer and his research is highly collaborative, working with multiple institutions on population-based research. In addition to his current research activities, Dr. Herman is pursuing a Master’s degree in Clinical Investigation.
Dr. Shari Goldfarb is a medical oncologist at the Memorial Sloan-Kettering Cancer Center. Her clinical work focuses on women with breast cancer. Her research focuses on characterizing and improving the negative effects of cancer therapy on sexual health and fertility in cancer survivors. She is currently developing methods to better identify and understand symptoms affecting cancer patients and their overall quality of life. Her research involves the assessment of biomarkers of ovarian reserve, development of novel therapeutic interventions, and development of instruments to better measure sexual health. She has presented her work at national and international conferences including the American Society of Clinical Oncology, the San Antonio Breast Cancer Symposium, the Multinational Association of Supportive Care in Cancer, and the American Society of Clinical Oncology Breast Cancer Symposium. Her research is funded by a grant from the Susan G. Komen Breast Cancer Foundation.
Find us on Facebook and let us know you’re coming!